ReActive Robotics GmbH, a Munich, Germany-based healthcare robotics company, received a seven-digit Series A funding round.
The round was led by MTIP MedTech Innovation Partners with participation from High-Tech Gründerfonds, Bayern Kapital and TQ-Group.
The company intends to use the funds for the development and clinical validation of several prototypes until 2017.
Led by Dr. Alexander Koenig, founder and CEO, ReActive Robotics develops adaptive and intelligent therapy robotics which automate early neurological abd orthopedic mobilization in the intensive care unit.
Using robotic modules that can be attached and detached on and from the patient bed, patients can be mobilized directly in their hospital bed.
The company’s device is scheduled to become available in Europe beginning of 2018.